Previous clinical studies using L-Carnitine supplementation have noted improvements in some cardiovascular risk factors (such as LDL, total cholesterol, and blood pressure).[3,4,5,8] Supplementation with L-Carnitine has also been found to improve feelings of hunger and fatigue induced by fasting in individuals with metabolic syndrome.[6] And, a 2020 systematic review and meta-analysis of 37 randomized controlled clinical trials found that: l-carnitine supplementation provides a modest reducing effect on body weight, BMI and fat mass, especially among adults with overweight/obesity. [7] It should be noted, though, that a previous 2014 meta-analysis found no benefit from L-carnitine supplementation in patients with cardiovascular disease.[14] Carnitine, Heart Disease & TMAO To further muddy the waters, other research notes an association between carnitine intake and increased plasma levels of pro-atherogenic trimethylamine N-oxide (TMAO).[9,10,16] TMAO has been identified as a risk factor for cardiovascular diseases and reported to be elevated in several cardiovascular events as well as type 2 diabetes

Total Medication: 8mg Weekly Dose: 2mg Total Doses: 4 Like the blue pen, this yellow pen is meant to last for four weeks
This trial is detailed in the comprehensive review by Pickart et al
This reduced appetite can lead to a decrease in calorie consumption, contributing to weight loss
Pancreatitis claims have not yet been incorporated into the scope of the existing multidistrict litigation (MDL 3094) centralized in the Eastern District of Pennsylvania